Compare BVFL & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BVFL | PROF |
|---|---|---|
| Founded | 1873 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.2M | 199.3M |
| IPO Year | N/A | N/A |
| Metric | BVFL | PROF |
|---|---|---|
| Price | $19.41 | $7.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 21.8K | ★ 84.5K |
| Earning Date | 01-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $38,669,000.00 | $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | $18.72 | ★ N/A |
| Revenue Growth | 1.69 | ★ 67.94 |
| 52 Week Low | $13.53 | $3.76 |
| 52 Week High | $19.74 | $7.99 |
| Indicator | BVFL | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 62.22 | 70.52 |
| Support Level | $18.93 | $7.19 |
| Resistance Level | $19.74 | $7.91 |
| Average True Range (ATR) | 0.54 | 0.40 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 74.16 | 98.66 |
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.